✦ LIBER ✦

Body fatness and bevacizumab-based therapy in metastatic colorectal cancer

✍ Scribed by Renehan, A. G.

Book ID: 126727774
Publisher: BMJ Publishing Group
Year: 2010
Tongue: English
Weight: 65 KB
Volume: 59
Category: Article
ISSN: 0017-5749
DOI: 10.1136/gut.2009.197210

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy, Bevacizumab, and Cetuximab

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

✍ Tol, Jolien; Koopman, Miriam; Cats, Annemieke; Rodenburg, Cees J.; Creemers, Gee 📂 Article 📅 2009 🏛 Massachusetts Medical Society 🌐 English ⚖ 637 KB

Bevacizumab in metastatic colorectal can

Bevacizumab in metastatic colorectal cancer and other settings

📂 Article 📅 2004 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 133 KB

Bevacizumab plus Irinotecan-Based Regime

Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer

✍ Heinemann, Volker; Hoff, Paulo M. 📂 Article 📅 2010 🏛 S. Karger AG 🌐 English ⚖ 213 KB

PCN22 Safety Profile of Bevacizumab in M

PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer

✍ Castillo, M.A.; Ubago, R.; Flores, S.; Rodríguez, R.; Beltrán, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Survival for Metastatic Colorectal Cance

Survival for Metastatic Colorectal Cancer in the Bevacizumab Era: A Population-based Analysis

✍ Daniel J. Renouf; Howard J. Lim; Caroline Speers; Diego Villa; Sharlene Gill; Ch 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 463 KB

Visceral fat area is an independent pred

Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer

✍ Guiu, B.; Petit, J. M.; Bonnetain, F.; Ladoire, S.; Guiu, S.; Cercueil, J.-P.; K 📂 Article 📅 2009 🏛 BMJ Publishing Group 🌐 English ⚖ 248 KB